2-(isopropylamino)cyclohexanol | 69592-28-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(isopropylamino)cyclohexanol
• 英文别名: (1S,2R)-(+)-2-Hydroxy-3-Cyclohexylisopropylamine；2-isopropylaminocyclohexanol；2-[(Propan-2-yl)amino]cyclohexan-1-ol；2-(propan-2-ylamino)cyclohexan-1-ol
• CAS: 69592-28-5
• 化学式: C₉H₁₉NO
• mdl: MFCD12801862
• 分子量: 157.256
• InChiKey: NXBJSUOOKXVSFX-UHFFFAOYSA-N

物化性质

• 沸点：
  242.6±33.0 °C(Predicted)
• 密度：
  0.94±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 储存条件：
  存储温度应保持在2-8°C，并请避免光线直射。

反应信息

• 作为产物：
  描述：

  氧化环己烯 、 异丙胺 在 aluminium(III) triflate 作用下， 以 甲苯 为溶剂， 反应 24.0h， 以43%的产率得到2-(isopropylamino)cyclohexanol
  参考文献：
  名称：

  Aluminium triflate: an efficient recyclable Lewis acid catalyst for the aminolysis of epoxides

  摘要：

  Epoxides are powerful starting materials for a range of useful materials and can be converted into, amongst others, amino alcohols. In this work, a range of epoxides was ring-opened using various alkyl- and arylamines under the action of aluminium triflate as a catalyst. This catalyst was found to be highly active, producing the desired amino alcohol products in high yields with low catalyst loadings. Additionally, it was shown that the aluminium triflate catalyst is recyclable by simple extraction into water and may be re-used several times. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2006.07.036

文献信息

• [EN] NLRP3 MODULATORS<br/>[FR] MODULATEURS DE NLRP3
  申请人：INNATE TUMOR IMMUNITY INC

  公开号：WO2019014402A1

  公开（公告）日：2019-01-17

  The present invention provides compounds of Formula (I): (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).

  本发明提供了Formula (I)的化合物：(I)其中所有变量均如本文所定义。这些化合物是NLRP3的调节剂，可用作治疗增殖性疾病的药物，例如在受试者（例如人类）中的癌症治疗。
• FUSED IMIDAZOLE DERIVATIVE HAVING TTK INHIBITORY ACTION
  申请人：Kusakabe Ken-ichi

  公开号：US20120059162A1

  公开（公告）日：2012-03-08

  Provided are a compound represented by general formula (1) and having a TTK inhibitory action and a medicine containing the compound. In formula (1), (X, Y, V, W) is (—N═, ═CR 1 —, ═N—, —CR 7 ═), (—CR 2 ═, ═N—, ═N—, —CR 7 ═), etc.; A is an (un)substituted aromatic hydrocarbon ring, etc.; L is a single bond, —C(═O)—NR A —, etc.; Z is a group represented by the formula —NR 3 R 4 or a group represented by the formula —OR 5 ; R 1 to R 3 , R 6 , and R 7 each is a hydrogen atom, etc.; R 4 and R 5 each is an (un)substituted alkyl, etc.; and R 8 is an (un)substituted cycloalkyl, etc.

  提供了一个由一般式（1）表示的化合物，具有TTK抑制作用，以及含有该化合物的药物。在式（1）中，（X，Y，V，W）为（—N═，═CR1—，═N—，—CR7═），（—CR2═，═N—，═N—，—CR7═），等等；A为（非）取代芳香烃环等；L为一个单键，—C(═O)—NRA—等；Z为由式—NR3R4或式—OR5表示的基团；R1至R3，R6和R7分别是氢原子等；R4和R5分别是（非）取代烷基等；R8是（非）取代环烷基等。
• TWO-PHOTON ABSORBING FLUOROPHORES AND METHOD FOR CELLULAR IMAGING USING THE SAME
  申请人：POSTECH ACADEMY-INDUSTRY FOUNDATION

  公开号：US20170327509A1

  公开（公告）日：2017-11-16

  The present invention relates to new one-photon or two-photon absorbing fluorophores, a method for preparing the same, and a method for cellular imaging using the same, and more particularly, to new two-photon absorbing fluorophores having higher fluorescence quantum yield and two-photon absorption cross-section value than those of the conventional two-photon absorbing fluorophore, acedan, and thus are promisingly applicable in bioimaging. The design strategy and the compounds according to the present invention may practically utilized for developing new D-π-A fluorophores.

  本发明涉及新的单光子或双光子吸收荧光团，以及制备该荧光团的方法和利用该荧光团进行细胞成像的方法，更特别地，涉及具有比传统的双光子吸收荧光团acedan的荧光量子产率和双光子吸收截面值更高的新的双光子吸收荧光团，因此在生物成像中有着广泛的应用前景。根据本发明的设计策略和化合物可实际用于开发新的D-π-A荧光团。
• [EN] HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES<br/>[FR] AMIDES HÉTÉROARYLE-BIPHÉNYLE POUR LE TRAITEMENT DE MALADIES ASSOCIÉES À PD-L1
  申请人：CHEMOCENTRYX INC

  公开号：WO2021076691A1

  公开（公告）日：2021-04-22

  Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R2a, R2b, R3, R3a, R4, R6, R7, R8, A, Z, X1 and n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

  提供了作为免疫调节剂有用的化合物。这些化合物具有包括立体异构体和其药用可接受盐的化学式（I），其中R2a、R2b、R3、R3a、R4、R6、R7、R8、A、Z、X1和n的定义如本文所述。还公开了与制备和使用这些化合物相关的方法，以及包含这些化合物的药物组合物。
• [EN] TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES<br/>[FR] COMPOSÉS TRIARYLES POUR LE TRAITEMENT DE MALADIES PD-L1
  申请人：CHEMOCENTRYX INC

  公开号：WO2020232256A1

  公开（公告）日：2020-11-19

  Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1a, R1b, R1c, R1d, R2a, R2b, R3, R3a, R4, R6, R7, R8, A, Z, X1 and n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

  提供了一些作为免疫调节剂有用的化合物。这些化合物具有公式（I），包括立体异构体和其药用盐，其中R1a、R1b、R1c、R1d、R2a、R2b、R3、R3a、R4、R6、R7、R8、A、Z、X1和n如本文所定义。还披露了与这些化合物的制备和使用相关的方法，以及包含这些化合物的药物组合物。